Equities

DocGo Inc

DCGO:NAQ

DocGo Inc

Actions
Health CareHealth Care Providers
  • Price (USD)4.32
  • Today's Change0.07 / 1.65%
  • Shares traded517.69k
  • 1 Year change-24.87%
  • Beta0.9558
Data delayed at least 15 minutes, as of Nov 25 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year DocGo Inc had net income fall -80.17% from 34.58m to 6.86m despite a 41.72% increase in revenues from 440.52m to 624.29m. An increase in the cost of goods sold as a percentage of sales from 64.88% to 68.70% was a component in the falling net income despite rising revenues.
Gross margin34.50%
Net profit margin4.17%
Operating margin6.88%
Return on assets6.35%
Return on equity10.06%
Return on investment8.97%
More ▼

Cash flow in USDView more

In 2023, cash reserves at DocGo Inc fell by 91.89m. Cash Flow from Financing totalled 1.12m or 0.18% of revenues. In addition the company used 64.22m for operations while cash used for investing totalled 29.88m.
Cash flow per share0.4261
Price/Cash flow per share9.39
Book value per share3.19
Tangible book value per share2.38
More ▼

Balance sheet in USDView more

DocGo Inc has a Debt to Total Capital ratio of 11.94%, a higher figure than the previous year's 2.77%.
Current ratio2.19
Quick ratio--
Total debt/total equity0.1354
Total debt/total capital0.1194
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.